Finance

Lists
Outlook: 41.7% bullish·13.9% bearish
Go to analysis
UNH:NYSE
UnitedHealth Group Inc
$407.46
+0.57%
(+2.32) 1D
$407.30
-0.04% (-0.16)
After hours
Closed: Nov 13, 4:00:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UNH...
Open
$407.89
High
$408.51
Low
$400.45
Mkt. cap
365.09B
Avg. vol.
5.81M
Volume
3.47M
Dividend
2.28%
Quarterly dividend
$2.32
Ex-dividend date
Dec 7, 2026
P/E ratio
23.25
52-wk high
$461.62
52-wk low
$255.96
EPS
$17.52
Beta
0.51
Shares outstanding
896.02M
No. of employees
390K
Open
$407.89
High
$408.51
Low
$400.45
Mkt. cap
365.09B
Avg. vol.
5.81M
Volume
3.47M
Dividend
2.28%
Quarterly dividend
$2.32
Ex-dividend date
Dec 7, 2026
P/E ratio
23.25
52-wk high
$461.62
52-wk low
$255.96
EPS
$17.52
Beta
0.51
Shares outstanding
896.02M
No. of employees
390K
News stories
From web sources and news partners
Profile
UnitedHealth Group Incorporated is an American multinational company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's fourth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500. UnitedHealth Group had a market capitalization of more than $300 billion as of year-end 2025. The company is the largest health insurer in the United States, insuring over 50 million people, and operates globally. UnitedHealth Group has faced numerous investigations, lawsuits, and fines, including SEC enforcement for stock option backdating, Medicare over-billing, unfair claims practices, mental health treatment denials, and anticompetitive behavior. Wikipedia
About UnitedHealth Group Inc
CEOStephen J. Hemsley
Employees390K
FoundedJan 1977
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websiteunitedhealthgroup.com
Analyst ratings
Based on 17 analysts giving stock ratings to UNH in the past 3 months
Strong buy
Buy
14
Hold
3
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for UNH in the last 3 months.
Highest
Current $407.46
$531.00 (+30.32%)
Average
$482.69 (+18.46%)
Lowest
$402.00 (-1.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$480.00
+17.8%
11/10/2026
Lance Wilkes
Bernstein
Buy
Maintained
$500.00
+22.7%
11/04/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
$531.00
+30.3%
10/27/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$487.00
+19.5%
10/27/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$500.00
+22.7%
10/22/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$498.00
+22.2%
10/19/2026
Lisa Gill
J.P. Morgan
Buy
Reiterated
$524.00
+28.6%
10/16/2026
Parker Snure
Raymond James
Buy
Maintained
$450.00
+10.4%
10/15/2026
Ryan Langston
TD Cowen
Hold
Maintained
$402.00
-1.3%
10/15/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
$472.00
+15.8%
10/15/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$506.00
+24.2%
10/13/2026
Michael Ha
Robert W. Baird
Hold
Reiterated
$427.00
+4.8%
10/14/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
$504.00
+23.7%
10/14/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$512.00
+25.7%
10/14/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$440.00
+8%
10/14/2026
A.J. Rice
UBS
Buy
Maintained
$490.00
+20.3%
10/12/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
10/08/2026
George Hill
Deutsche Bank
Hold
Maintained
-
-
08/03/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$500.00
+22.7%
07/17/2026
David Toung
Argus Research
Buy
Maintained
$470.00
+15.3%
07/17/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$500.00
+22.7%
07/17/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
$475.00
+16.6%
07/14/2026
Sidharth Sahoo
HSBC
Hold
Maintained
$380.00
-6.7%
07/06/2026
Michael Craig Jones
Bank of America Securities
Buy
Reiterated
$475.00
+16.6%
06/24/2026
John Ransom
Raymond James
Buy
Maintained
$370.00
-9.2%
04/22/2026
David Windley
Jefferies
Buy
Maintained
$373.00
-8.5%
04/20/2026
Bram Kaplan
J.P. Morgan
Buy
Maintained
$389.00
-4.5%
02/02/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$440.00
+8%
01/28/2026
Last report
Oct 13, 2026
Fiscal period
Q3 2026
$4.69 / $4.14
+13.26%beat
Revenue / Est. (USD)
112.69B / 111.49B
+1.08%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
113.61B
111.72B
112.03B
112.69B
Cost of goods sold
94.10B
86.31B
88.73B
90.69B
Cost of revenue
94.10B
86.31B
88.73B
90.69B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.60B
15.39B
14.27B
14.37B
Operating expense
16.71B
16.42B
15.31B
15.44B
Total operating expenses
110.81B
102.73B
104.04B
106.13B
Operating income
2.80B
8.99B
7.99B
6.56B
Other non operating income
-
-
-
-
EBT including unusual items
-720.00M
7.96B
6.97B
5.52B
EBT excluding unusual items
1.83B
8.04B
7.03B
5.60B
Income tax expense
-938.00M
1.48B
1.30B
1.22B
Effective tax rate
130.28%
18.61%
18.63%
22.16%
Other operating expenses
-
-
-
-
Net income
10.00M
6.28B
5.48B
4.11B
Net profit margin
0.01%
5.62%
4.89%
3.65%
Earnings per share
2.11
7.23
6.38
4.69
Interest and investment income
-
-
-
-
Interest expense
-974.00M
-955.00M
-962.00M
-963.00M
Net interest expenses
-974.00M
-955.00M
-962.00M
-963.00M
Depreciation and amortization charges
1.12B
1.03B
1.04B
1.07B
EBITDA
3.92B
10.02B
9.03B
7.64B
Gain or loss from assets sale
-784.00M
72.00M
61.00M
76.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps